ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Infectious Disease

Top Infectious Disease Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LAWRENCE KIDD M.D.

Infectious Disease

11,899

$537K

407
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 44%

$45
Average prescription price

Avg: $222

LINSEY PHILIP M.D.

Infectious Disease

11,256

$1.3M

406
260 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 44%

$115
Average prescription price

Avg: $222

JONATHAN ADLER MD

Infectious Disease

10,440

$632K

580
549 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 44%

$61
Average prescription price

Avg: $222

ALEXANDER GRIFFIN M.D.

Infectious Disease

10,317

$1.23M

335
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 44%

$119
Average prescription price

Avg: $222

TAMIM HINEDI M.D.

Infectious Disease

8,958

$638K

386
243 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 44%

$71
Average prescription price

Avg: $222

AMELIA JAWOREK M.D.

Infectious Disease

6,416

$707K

334
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 44%

$110
Average prescription price

Avg: $222

MARTHA SANCHEZ MD

Infectious Disease

6,401

$1.58M

257
53 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 44%

$247
Average prescription price

Avg: $222

JONATHAN PINCUS MD

Infectious Disease

5,491

$705K

209
99 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 44%

$128
Average prescription price

Avg: $222

STEVEN KEENHOLTZ M.D.

Infectious Disease

5,476

$802K

451
369 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 44%

$146
Average prescription price

Avg: $222

SCOTT PAPARELLO D.O.

Infectious Disease

5,194

$270K

396
323 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 44%

$52
Average prescription price

Avg: $222

ASHA NAIDU MD

Infectious Disease

4,979

$313K

188
141 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 44%

$63
Average prescription price

Avg: $222

BRIAN CILLEY DO

Infectious Disease

4,964

$764K

269
50 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 44%

$154
Average prescription price

Avg: $222

LESLIE LINARES M.D.

Infectious Disease

4,162

$292K

209
123 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 44%

$70
Average prescription price

Avg: $222

IOANA BICA M.D.

Infectious Disease

4,075

$1.63M

113
16 are 65+

28%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 44%

$399
Average prescription price

Avg: $222

HANUMARA CHOWDRI MD

Infectious Disease

3,988

$409K

232
193 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 44%

$103
Average prescription price

Avg: $222

CLAUDIA MARTORELL MD

Infectious Disease

3,014

$2.83M

139
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 44%

$939
Average prescription price

Avg: $222

RANJAN CHOWDHRY M.D.

Infectious Disease

2,905

$195K

243
173 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 44%

$67
Average prescription price

Avg: $222

JASON FAULHABER M.D.

Infectious Disease

2,724

$729K

77
17 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 44%

$268
Average prescription price

Avg: $222

PRESCOTT LEE MD

Infectious Disease

2,691

$136K

253
253 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 44%

$50
Average prescription price

Avg: $222

PATRICIA TORO MD

Infectious Disease

2,624

$111K

36
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 44%

$42
Average prescription price

Avg: $222

SREELEKHA GOPINATH M.D.

Infectious Disease

2,620

$115K

159
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 44%

$44
Average prescription price

Avg: $222

KATHERINE MCGOWAN MD

Infectious Disease

2,495

$722K

102
56 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 44%

$289
Average prescription price

Avg: $222

STEPHANIE MARGLIN M.D.

Infectious Disease

2,483

$643K

102
48 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 44%

$259
Average prescription price

Avg: $222

PADMINI HARIGOPAL M.D

Infectious Disease

2,311

$783K

129
19 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 44%

$339
Average prescription price

Avg: $222

BELA BASHAR MD

Infectious Disease

2,072

$595K

103
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 44%

$287
Average prescription price

Avg: $222

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank